Complex association between alanine aminotransferase activity and mortality in general population: A systematic review and meta-analysis of prospective studies

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Liu, Zhengtao ^a   Ning, Huaijun ^b   Que, Shuping ^a,b   Wang, Linlin ^a   Qin, Xue ^a   Peng, Tao ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b Guangxi Women and Children Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; FOLLOW UP; GERIATRIC PATIENT; HUMAN; LONG TERM SURVIVAL; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SAMPLE SIZE; SYSTEMATIC REVIEW; ADULT; AGE; AGED; FEMALE; HEALTH SURVEY; MALE; METABOLISM; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PUBLISHING; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; PUBLICATION BIAS;

EID: 84898426325     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091410     Document Type: Review

References (73)

1. Kim W, Flamm SL, Di Bisceglie AM, Bodenheimer HC (2008) Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47: 1363-1370. (Pubitemid 351547922)
2. Pratt DS, Kaplan MM (2000) Evaluation of abnormal liver-enzyme results in asymptomatic patients. New England Journal of Medicine 342: 1266-1271. (Pubitemid 30235957)
3. Hyeon CK, Chung MN, Sun HJ, Kwang HH, Kyu Oh D, et al. (2004) Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. Bmj 328: 983.
4. Nakamura K, Okamura T, Kanda H, Hayakawa T, Okayama A, et al. (2006) The value of combining serum alanine aminotransferase levels and body mass index to predict mortality and medical costs: a 10-year follow-up study of National Health Insurance in Shiga, Japan. Journal of epidemiology 16: 15-20. (Pubitemid 43055683)
5. Lee TH, Kim W, Benson JT, Therneau TM, Melton LJ (2008) Serum aminotransferase activity and mortality risk in a United States community. Hepatology 47: 880-887. (Pubitemid 351449679)
6. Ioannou GN, Weiss NS, Boyko EJ, Mozaffarian D, Lee SP (2006) Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology 43: 1145-1151. (Pubitemid 43724639)
7. Olynyk JK, Knuiman MW, Divitini ML, Davis TM, Beilby J, et al. (2009) Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population. The American journal of gastroenterology 104: 1715-1722.
8. Arndt V, Brenner H, Rothenbacher D, Zschenderlein B, Fraisse E, et al. (1998) Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality. International archives of occupational and environmental health 71: 405-412. (Pubitemid 28438418)
9. Schindhelm RK, Dekker JM, Nijpels G, Bouter LM, Stehouwer CD, et al. (2007) Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 191: 391-396. (Pubitemid 46400701)
10. Goessling W, Massaro JM, Vasan RS, D'Agostino Sr RB, Ellison RC, et al. (2008) Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 135: 1935.
11. Ruhl CE, Everhart JE (2009) Elevated serum alanine aminotransferase and γ-glutamyltransferase and mortality in the United States population. Gastroenterology-Orlando 136: 477.
12. Yun KE, Shin CY, Yoon YS, Park HS (2009) Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans. Atherosclerosis 205: 533.
13. Ford I, Mooijaart SP, Lloyd S, Murray HM, Westendorp RG, et al. (2011) The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. International journal of epidemiology 40: 1530-1538.
14. Schooling CM, Kelvin EA, Jones HE (2012) Alanine transaminase has opposite associations with death from diabetes and ischemic heart disease in NHANES III. Annals of Epidemiology.
15. Elinav E, Ackerman Z, Maaravi Y, Ben-Dov IZ, Ein-Mor E, et al. (2006) Low Alanine Aminotransferase Activity in Older People Is Associated with Greater Long-Term Mortality. Journal of the American Geriatrics Society 54: 1719-1724. (Pubitemid 44665211)
16. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, et al. (2009) Alanine aminotransferase, c-glutamyltransferase, and incident diabetes The British Women's Heart and Health Study and meta-analysis. Diabetes Care 32: 741-750.
17. Hovinen SM, Pitkala KH, Tilvis RS, Strandberg TE (2010) Alanine aminotransferase activity and mortality in older people. Journal of the American Geriatrics Society 58: 1399-1401.
18. Koehler EM, Sanna D, Hansen BE, Rooij FJ, Heeringa J, et al. (2013) Serum Liver Enzymes Are Associated With All-Cause Mortality In An Elderly Population. Liver International.
19. Le Couteur DG, Blyth FM, Creasey HM, Handelsman DJ, Naganathan V, et al. (2010) The association of alanine transaminase with aging, frailty, and mortality. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 65: 712-717.
20. Dong MH, Bettencourt R, Brenner DA, Barrett-Connor E, Loomba R (2012) Serum levels of alanine aminotransferase decrease with age in longitudinal analysis. Clinical Gastroenterology and Hepatology 10: 285-290. e281.
21. Dong MH, Bettencourt R, Barrett-Connor E, Loomba R (2010) Alanine aminotransferase decreases with age: the Rancho Bernardo Study. PloS one 5: e14254.
22. Elinav E, Ben-Dov IZ, Ackerman E, Kiderman A, Glikberg F, et al. (2005) Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern. The American journal of gastroenterology 100: 2201-2204.
23. Yang MC, McLean AJ, Le Couteur DG (2002) Age-Related Alteration in Hepatic Disposition of the Neurotoxin 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine and Pesticides. Pharmacology & toxicology 90: 203-207. (Pubitemid 34478342)
24. Schmucker DL (2005) Age-related changes in liver structure and function: implications for disease? Experimental gerontology 40: 650-659.
25. Marchesini G, Targher G (2011) Commentary: Liver enzymes and the risk of adverse cardiovascular outcomes - the lower, the better? International journal of epidemiology 40: 1539-1541.
26. Vento S, Nobili V (2008) Aminotransferases as predictors of mortality. The Lancet 371: 1822-1823. (Pubitemid 351734530)
27. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine 151: 264-269.
28. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Metaanalysis of observational studies in epidemiology. JAMA: the journal of the American Medical Association 283: 2008-2012.
29. Wells G, Shea B, O'Connell D, Peterson P, Welch V, et al. (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute.
30. Slee VN (1978) The International classification of diseases: ninth revision (ICD-9). Annals of internal medicine 88: 424-426.
31. Harris R, Bradburn M, Deeks J, Harbord R, Altman D, et al. (2008) Metan: fixed-and random-effects meta-analysis. Stata Journal 8: 3.
32. Berlin JA, Longnecker MP, Greenland S (1993) Meta-analysis of epidemiologic dose-response data. Epidemiology 4: 218-228. (Pubitemid 23159532)
33. Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized dose-response data. Stata Journal 6: 40-57. (Pubitemid 43708443)
34. Sharp S (2012) Meta-analysis regression. Stata Technical Bulletin 7.
35. Program ESotTRotNCE (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285.
36. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ: British Medical Journal 327: 557.
37. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controlled clinical trials 7: 177-188. (Pubitemid 17189972)
38. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics: 1088-1101.
39. Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315: 629-634. (Pubitemid 27387172)
40. Steichen TJ (1998) Tests for publication bias in meta-analysis. Stata Technical Bulletin 7.
41. Lee BS, Cho YK, Jeong SH, Lee JH, Lee D, et al. (2013) Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs. Journal of medical virology.
42. Giannini EG, Testa R, Savarino V (2005) Liver enzyme alteration: a guide for clinicians. Canadian medical association journal 172: 367-379. (Pubitemid 40208726)
43. Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. The American journal of gastroenterology 98: 960-967. (Pubitemid 36733754)
44. Pendino GM, Mariano A, Surace P, Caserta CA, Fiorillo MT, et al. (2005) Prevalence and etiology of altered liver tests: A population-based survey in a Mediterranean town. Hepatology 41: 1151-1159. (Pubitemid 40593924)
45. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, et al. (2007) Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. Journal of gastroenterology and hepatology 22: 1482-1489. (Pubitemid 47274571)
46. Woodhouse K, Wynne H (1988) Age-related changes in liver size and hepatic blood flow. Clinical pharmacokinetics 15: 287-294.
47. Hui WS, Liu Z, Ho SC (2010) Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. European journal of epidemiology 25: 375-384.
48. Wannamethee SG, Shaper AG, Lennon L, Whincup PH (2005) Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28:2913-2918. (Pubitemid 43942924)
49. Lee JK, Shim JH, Lee HC, Lee SH, Kim KM, et al. (2010) Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology. Hepatology 51: 1577-1583.
50. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, et al. (2002) Updated definitions of healthy ranges for serum alanine aminotransferase levels. Annals of internal medicine 137: 1-10.
51. Al-hamoudi W, Ali S, Hegab B, Elsiesy H, Hashim A, et al. (2013) Revising the Upper Limit of Normal for Levels of Serum Alanine Aminotransferase in a Middle Eastern Population with Normal Liver Histology. Digestive diseases and sciences: 1-7.
52. Ruhl CE, Everhart JE (2012) Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology 55: 447-454.
53. Yun JE, Kim SY, Kang H-C, Lee SJ, Kimm H, et al. (2010) Alanine aminotransferase is associated with metabolic syndrome independently of insulin resistance. Circulation journal: official journal of the Japanese Circulation Society 75: 964-969.
54. Limdi J, Hyde G (2003) Evaluation of abnormal liver function tests. Postgraduate medical journal 79: 307-312. (Pubitemid 36819456)
55. Liu Z, Que S, Ning H, Wang L, Peng T (2013) Elevated Alanine Aminotransferase Is Strongly Associated with Incident Metabolic Syndrome: A Meta-Analysis of Prospective Studies. PloS one 8.
56. Liu Z, Hu Y, Yang X, Tan A, Gao Y, et al. (2012) Combinative analysis of factors influence serum alanine aminotransferase activity in adult male population from southern China. Clinical biochemistry.
57. Adams WL, Garry PJ, Rhyne R, Hunt WC (1990) Alcohol intake in the healthy elderly: Changes with age in a cross-sectional and longitudinal study. Journal of the American Geriatrics Society.
58. Molander RC, Yonker JA, Krahn DD (2010) Age-Related Changes in Drinking Patterns From Mid-to Older Age: Results From the Wisconsin Longitudinal Study. Alcoholism: Clinical and Experimental Research 34: 1182-1192.
59. Tolman KG (2002) The liver and lovastatin. The American journal of cardiology 89: 1374-1380.
60. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in medicine 17: 2815-2834. (Pubitemid 28562978)
61. Du G, Song Z, Zhang Q (2013) Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: A meta-analysis of prospective cohort studies. Preventive medicine.
62. Lee D-H, Buijsse B, Steffen L, Holtzman J, Luepker R, et al. (2009) Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey. European Journal of Cardiovascular Prevention & Rehabilitation 16: 16-20.
63. Kazemi-Shirazi L, Endler G, Winkler S, Schickbauer T, Wagner O, et al. (2007) Gamma glutamyltransferase and long-term survival: is it just the liver? Clinical chemistry 53: 940-946. (Pubitemid 46744252)
64. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, et al. (2005) c- Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults. Circulation 112: 2130-2137. (Pubitemid 41475806)
65. Polder JJ, Bonneux L, Meerding WJ, Van Der Maas PJ (2002) Age-specific increases in health care costs. The European Journal of Public Health 12: 57-62. (Pubitemid 34269962)
66. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, et al. (2004) Global epidemiology of hepatitis B virus. Journal of clinical gastroenterology 38: S158-S168.
67. Pappas G, Queen S, Hadden W, Fisher G (1993) The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. New England Journal of Medicine 329: 103-109. (Pubitemid 23188825)
68. Singh GK, Azuine RE, Siahpush M, Kogan MD (2012) All-cause and cause-specific mortality among US youth: socioeconomic and rural-urban disparities and international patterns. Journal of Urban Health: 1-18.
69. Turrell G, Mathers C (2001) Socioeconomic inequalities in all-cause and specific-cause mortality in Australia: 1985-1987 and 1995-1997. International journal of epidemiology 30: 231-239. (Pubitemid 32447819)
70. Riley RD, Lambert PC, Abo-Zaid G (2010) Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ British medical journal 340: 521-525.
71. Stewart LA (1995) Practical methodology of meta-analyses (overviews) using updated individual patient data. Statistics in medicine 14: 2057-2079.
72. Stewart L, Parmar M (1993) Meta-analysis of the literature or of individual patient data: is there a difference? The Lancet 341: 418-422. (Pubitemid 23048157)
73. Simmonds MC, Higginsa JP, Stewartb LA, Tierneyb JF, Clarke MJ, et al. (2005) Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clinical Trials 2: 209-217. (Pubitemid 40910470)